-

WHO’s Actions Contradict “Zero Tolerance” Stance on Sexual Harassment and Abuse, says AHF

LOS ANGELES--(BUSINESS WIRE)--Following reports that the World Health Organization reinstated staffers accused of mishandling a sexual abuse scandal during an Ebola outbreak in the Democratic Republic of Congo – AIDS Healthcare Foundation condemns the decision to reappoint the employees as a sign the U.N. system is still struggling to handle sexual harassment and abuse allegations adequately.

“It is disappointing that no matter how many chances the WHO has had to correct past mistakes when addressing sexual misbehavior at the hands of its employees, it continues to make decisions that run counter to its commitment to ‘zero tolerance’ on sexual harassment and abuse,” said AHF Chief of Global Advocacy and Policy Terri Ford. “We and civil society more broadly disapprove of the pervasiveness and tacit acceptance of sexual misconduct within the WHO and the U.N. system. Those in charge must communicate unequivocally in their actions and words that sexual exploitation will not be tolerated in any form.”

AHF has advocated for justice for sex abuse victims and for decision-makers within the U.N. system to hold perpetrators accountable dating back to the scandal at UNAIDS and its then Executive Director Michel Sidibé, who later resigned before his term ended.

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323 308 1833 work, +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

AIDS Healthcare Foundation


Release Versions
Hashtags

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323 308 1833 work, +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

More News From AIDS Healthcare Foundation

Hantavirus Reveals Latin America Is Unprepared, Warns The Lancet Commentary

MEXICO CITY--(BUSINESS WIRE)--The Latin American Technical Working Group, composed of former health ministers from the region, public health experts, epidemiologists, academics, and civil society representatives, published a new comment in The Lancet arguing that Latin America urgently needs a regional rapid-response platform to prevent, prepare for, and respond to infectious threats. Read the full text in The Lancet here. The comment, written collectively by the Technical Working Group, takes...

AHF Welcomes Lula–Tedros Call for Equity in Pandemic Agreement, Warns against Rushing Empty Deal

MIAMI, GENEVA & SÃO PAULO--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) and the AHF Global Public Health Institute welcome the open letter issued by President Luiz Inácio Lula da Silva of Brazil and World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus on the occasion of the G7 Summit, calling on the leaders of the G7, G20, BRICS, and all nations to finish the Pathogen Access and Benefit-Sharing (PABS) annex of the WHO Pandemic Agreement. AHF particularly commends t...

AHF: Ebola Outbreak Exposes Need for Stronger Investment in Preparedness

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) calls for stronger investments in Ebola preparedness and response as the current outbreak in the Democratic Republic of the Congo and Uganda underscores the continued threat posed by the deadly disease and the urgent need to strengthen public health systems across Africa. The outbreak is caused by the Bundibugyo virus strain, for which there is currently no approved vaccine or specific treatment. While progress has been made in...
Back to Newsroom